These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 2195854)

  • 41. From transmitters to treatment: the pharmacotherapy of behavioural disturbances in dementia.
    Herrmann N; Lanctôt KL
    Can J Psychiatry; 1997 Jun; 42 Suppl 1():51S-64S. PubMed ID: 9220129
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Verbal and physical non-aggressive agitated behaviors in elderly persons with dementia: robustness of syndromes.
    Cohen-Mansfield J; Libin A
    J Psychiatr Res; 2005 May; 39(3):325-32. PubMed ID: 15725431
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacologic treatment of agitation in dementia: a comprehensive review.
    Lantz MS; Marin D
    J Geriatr Psychiatry Neurol; 1996 Jul; 9(3):107-19. PubMed ID: 8873873
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Therapeutic use of carbamazepine for treatment of agitation and affective disorders in geriatric psychiatry patients].
    Lemke MR; Stuhlmann W
    Psychiatr Prax; 1994 Jul; 21(4):147-50. PubMed ID: 7938323
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Psychopharmacological treatment of elderly patients with dementia. Recommendations and guidelines].
    Gulmann NC
    Ugeskr Laeger; 1993 Mar; 155(10):709-14. PubMed ID: 8456513
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Anxiety, depression and dementia].
    Goudemand M; Thomas P
    Rev Prat; 1994 Jun; 44(11):1448-52. PubMed ID: 7939211
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Managing common behavioral problems in dementia. How to improve quality of life for patients and families.
    Burke JR; Morgenlander JC
    Postgrad Med; 1999 Oct; 106(5):131-4, 139-40. PubMed ID: 10560472
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacologic therapy for behavioral symptoms of Alzheimer's disease.
    Tariot PN; Ryan JM; Porsteinsson AP; Loy R; Schneider LS
    Clin Geriatr Med; 2001 May; 17(2):359-76. PubMed ID: 11375140
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Behavioral Problems and Dementia.
    Volicer L
    Clin Geriatr Med; 2018 Nov; 34(4):637-651. PubMed ID: 30336992
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sensory and nurturing nonpharmacological interventions for behavioral and psychological symptoms of dementia.
    Fitzsimmons S; Barba B; Stump M
    J Gerontol Nurs; 2014 Nov; 40(11):9-15. PubMed ID: 25310097
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Depression in dementia patients: issues and challenges for a physician.
    Pattanayak RD; Sagar R
    J Assoc Physicians India; 2011 Oct; 59():650-2. PubMed ID: 22479745
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anticonvulsant and other non-neuroleptic treatment of agitation in dementia.
    Tariot PN; Schneider LS; Katz IR
    J Geriatr Psychiatry Neurol; 1995 Oct; 8 Suppl 1():S28-39. PubMed ID: 8561842
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Agitation and depression in frail nursing home elderly patients with dementia: treatment characteristics and service use.
    Bartels SJ; Horn SD; Smout RJ; Dums AR; Flaherty E; Jones JK; Monane M; Taler GA; Voss AC
    Am J Geriatr Psychiatry; 2003; 11(2):231-8. PubMed ID: 12611753
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Behavioral problems in dementia. Strategies for pharmacologic and nonpharmacologic management.
    Smith AG
    Postgrad Med; 2004 Jun; 115(6):47-52, 55-6. PubMed ID: 15216573
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Adherence to medication in patients with dementia: predictors and strategies for improvement.
    Arlt S; Lindner R; Rösler A; von Renteln-Kruse W
    Drugs Aging; 2008; 25(12):1033-47. PubMed ID: 19021302
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Double-blind clinical and psychologic study of ergoloid mesylates (Hydergine) in subjects with senile mental deterioration.
    van Loveren-Huyben CM; Engelaar HF; Hermans MB; van der Bom JA; Leering C; Munnichs JM
    J Am Geriatr Soc; 1984 Aug; 32(8):584-8. PubMed ID: 6379022
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Optimal management of behavioural disorders associated with dementia.
    Class CA; Schneider L; Farlow MR
    Drugs Aging; 1997 Feb; 10(2):95-106. PubMed ID: 9061267
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Broadening the search for safe treatments in dementia agitation a possible role for low-dose opioids?
    Brown R
    Int J Geriatr Psychiatry; 2010 Oct; 25(10):1085-6. PubMed ID: 20872931
    [No Abstract]   [Full Text] [Related]  

  • 60. Psychosis, behavioral disturbance, and the use of neuroleptics in dementia.
    Devanand DP; Sackeim HA; Mayeux R
    Compr Psychiatry; 1988; 29(4):387-401. PubMed ID: 2900712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.